home All News open_in_new Full Article

FDA approves new UTI antibiotic that may help patients with recurring infections

A commercial launch of the antibiotic in the U.S. is planned during the second half of 2025


today 2 w. ago attach_file Science

attach_file Politics
attach_file Science
attach_file Events
attach_file Science
attach_file Politics
attach_file Economics
attach_file Events
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Science
attach_file Events
attach_file Events
attach_file Science
attach_file Science
attach_file Events
attach_file Economics
attach_file Events
attach_file Politics
attach_file Politics


ID: 3808911146
Add Watch Country

arrow_drop_down